Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
J. Domagala-Kulawik, T. Skirecki, G. Hoser (Warsaw, Poland). Circulating CD133(+) stem cells in lung cancer patients. Eur Respir J 2011; 38: Suppl. 55, 2797

Member's Comments

No comment yet.

Related content which might interest you: EpCAM-positive circulating cells in lung cancer patients Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Intersections of lung progenitor cells, lung disease and lung cancer Source: Eur Respir Rev, 26 (144) 170054; 10.1183/16000617.0054-2017 Year: 2017 Lung stem cells and lung cancer Source: ERS Lung Science Conference 2017 Year: 2017 Stem cells and lung cancer Source: Eur Respir Monogr 2021; 91: 340-352 Year: 2021 Exploration of the evidence of cancer stem cells in lung cancer Source: Annual Congress 2009 - Hot topics in molecular pathology and functional genomics of lung cancer Year: 2009 Modulation of tumor-microenvironmental factors and cancer growth in co-cultures of fresh human lung tissue and patient-derived cancer cells Source: International Congress 2018 – Lung cancer: from the bench to the bedside Year: 2018 Serum tumor markers in lung cancer patients Source: Annual Congress 2007 - Biology, diagnosis and rare tumours in thoracic malignancies Year: 2007 The expression and clinical significance of PD-L1+CD68+ macrophages in peripheral blood mononuclear cells of non-small cell lung cancer Source: Annual Congress 2011 - Biomarkers and other new methods for lung cancer Year: 2011 Circulating free DNA, new dynamic marker in nonsmall cell lung cancer patients? Source: Eur Respir J 2015; 46: 1548-1550 Year: 2015 Influence mesenchymal stem cells on aneuploidy of the tumor cells of Lewis lung carcinoma Source: International Congress 2019 – Biology of lung cancer Year: 2019 The role of stem cells in cancer Source: Research Seminar 2015 Year: 2015 Prognostic significance of cytokeratin positive cells in bone marrow of non-small cell lung cancer patients Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Human mesenchymal stem cell exosomes attenuate inflammation of lung epithelial cells through miR-223 in acute lung injury Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Clinical implication of stem cell markers in N2 positive non-small cell lung cancer Source: Annual Congress 2012 - Prognosis of lung cancer Year: 2012 Evaluation of serum tumour markers in the lung cancer patients Source: Eur Respir J 2002; 20: Suppl. 38, 268s Year: 2002 In vitro and in vivo application of the GILUPI cell collector system for the isolation and characterization of circulating tumor cells (CTCs) in lung cancer patients Source: International Congress 2015 – Biomarkers, immunology and molecular pathology of lung cancer Year: 2015 The ability of autologous dendritic cells to destroy NSCLC cells in vitro Source: Annual Congress 2007 - Biology in thoracic oncology Year: 2007 Abnormal abundance of senescent fibroblasts in the tumor stroma of non-small cell lung cancer patients Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer Year: 2013 Extracts of lung cancer cells reveal antitumour antibodies in sera of patients with lung cancer Source: Eur Respir J 2003; 21: 342-346 Year: 2003